細胞番号 : 細胞名
RCB0490 : NEC14
update : 2024/05/16
|
細胞特性(Comment:英) | Embryonal carcinoma, testis. Application consideration |
細胞特性(日) | 睾丸由来奇形腫細胞。マイコプラズマ除去処理済。培養開始にあたっての注意 |
細胞特性(寄託者記述:英) | |
細胞特性(寄託者記述:日) | |
使用条件(英) | There is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC. |
使用条件(日) | 基礎的研究につきましては、使用制限はありません。商業利用や特許取得を目的とする場合は、事前に必ず理研細胞バンクに連絡をすること。 |
備考(英) | |
備考(日) | |
提供申込書類(英) |
Order Form(C-0005.pdf)
 
MTA(C-0007.pdf)
 
MTA(C-0007p.pdf)
 
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
提供申込書類(日) |
依頼書C-0001.pdf
 
同意書(非営利学術目的)C-0003.pdf
 
同意書(営利目的)C-0003p.pdf
 
|
提供同意書は、使用機関の種類や目的に応じて、非営利学術目的 (C-XXXX) と営利目的 (C-XXXXp) の2種類があります。該当する提供同意書をご使用ください(詳細)。特許等の取得及び商業利用等は事前に必ず cellbank.brc@riken.jp までご連絡ください。
|
提供手数料 |
手数料とお支払いについてはこちらをご覧ください。 |
細胞基本情報
|
|
寄託者 |
Motoyama, Teiichi
|
樹立者 |
Motoyama, Teiichi
|
寄託日 |
1990
|
動物種 |
_human
< Mammals
|
属名 |
Homo
|
種名 |
sapiens
|
人種 |
Japanese
|
性別 |
Male
|
齢 |
26 years
|
採取組織 |
testis
|
病名 |
teratocarcinoma
|
細胞分類 |
cancer
|
入手歴 |
Motoyama - JCRB(FDSC0006)
|
メモ_1 |
Mycoplasma was eliminated with MC-210 by the depositor.
|
|
細胞寿命 |
infinite
|
細胞形態 |
other
|
Cellosaurus(Expasy) |
CVCL_3070
|
細胞培養・検査情報
| |
寄託時情報 |
ロット情報 |
培地・試薬情報 |
培地・試薬一覧はこちらをご覧ください。 |
|
培養形態 |
|
Adherent cells
|
培地 |
|
RPMI1640 + 10% FBS
|
抗生物質 |
|
Free
|
|
継代方法 |
|
pipetting
|
|
継代密度 |
|
1 : 8 split
|
継代・培地交換頻度 |
|
Subculture : 2 times/week
|
培養最適温度 |
|
37
℃
|
二酸化炭素濃度 |
|
5
%
|
凍結培地 |
|
Medium + 10% DMSO
|
凍結方法 |
|
Slow freezing
|
マイコプラズマ/アコレプラズマ |
|
(-)
|
ウィルス(HIV) |
|
(-)
|
アイソザイム検査 |
|
LD, NP, G6PD, AST, MPI, PepB
|
染色体検査 |
|
54-61(50) : 56(4),57(5),58(9),59(8),60(14),61(5)
|
個体識別検査 |
|
OK
|
画像情報 |
寄託時情報 | ロット情報 |
|
|
文献情報 |
Reference(英) |
4件
|
Reference(日) |
3件
|
利用者成果(英) |
16件
|
利用者成果(日) |
0件
|
利用者成果(英) |
11326
Abe T, Kohashi K, Takemoto J, Kinoshita F, Eto M, Oda Y.
Clinicopathological Significance and Antitumor Effect of MPHOSPH1 in Testicular Germ Cell Tumor.
J Cancer
2018
PubMed ID: 30519350
DOI: 10.7150/jca.25279
|
6403
Terasaka N, Futai K, Katoh T, Suga H.
A human microRNA precursor binding to folic acid discovered by small RNA transcriptomic SELEX.
RNA
2016
22(12):1918-1928
PubMed ID: 27852928
DOI: 10.1261/rna.057737.116
|
7130
Kita H, Okamoto K, Kushima R, Kawauchi A, Chano T.
Dimethyl sulfoxide induces chemotherapeutic resistance in the treatment of testicular embryonal carcinomas.
Oncol Lett
2015
10:661-666
PubMed ID: 26622550
DOI: 10.3892/ol.2015.3306
|
6395
Ando S, Matsuoka T, Kawai K, Sugita S, Joraku A, Kojima T, Suetomi T, Miyazaki J, Fujita J, Nishiyama H.
Expression of the oncoprotein gankyrin and phosphorylated retinoblastoma protein in human testis and testicular germ cell tumor.
Int J Urol
2014
21(10):992-8
PubMed ID: 24861729
DOI: 10.1111/iju.12484
|
6398
Nagano K, Yamashita T, Inoue M, Higashisaka K, Yoshioka Y, Abe Y, Mukai Y, Kamada H, Tsutsumi Y, Tsunoda S
Eph receptor A10 has a potential as a target for a prostate cancer therapy.
Biochem Biophys Res Commun
2014
450(1):545-9
PubMed ID: 24924629
DOI: 10.1016/j.bbrc.2014.06.007
|
6394
Behjati R, Kawai K, Inadome Y, Kano J, Akaza H, Noguchi M.
APAF-1 is related to an undifferentiated state in the testicular germ cell tumor pathway.
Cancer Sci
2011
102(1):267-74
PubMed ID: 20977544
DOI: 10.1111/j.1349-7006.2010.01750.x
|
8246
Tominaga A, Sugawara H, Futagawa T, Inoue K, Sasaki K, Minamino N, Hatakeyama M, Handa H, Miyata A.
Characterization of the testis-specific promoter region in the human pituitary adenylate cyclase-activating polypeptide (PACAP) gene.
Genes Cells
2010
15:595-606
PubMed ID: 20500521
DOI: 10.1111/j.1365-2443.2010.01403.x
|
6387
Minami K, Chano T, Kawakami T, Ushida H, Kushima R, Okabe H, Okada Y, Okamoto K.
DNMT3L is a novel marker and is essential for the growth of human embryonal carcinoma.
Clin Cancer Res
2010
16(10):2751-9
PubMed ID: 20460473
DOI: 10.1158/1078-0432.CCR-09-3338
|
3374
Yanagisawa, Ayano, Endo, Chisato, Okawa, Katsuya, Shitara, Shingo, Kugoh, Hiroyuki, Kakitani, Makoto, Oshimura, Mitsuo, Tomizuka, Kazuma
Generation of chromosome-specific monoclonal antibodies using in vitro-differentiated transchromosomic mouse embryonic stem cells.
Stem Cells
2005
23:1479-88
PubMed ID: 16081665
DOI: 10.1634/stemcells.2004-0369
|
2888
Sekiguchi T, Iida H, Fukumura J, Nishimoto T
Human DDX3Y, the Y-encoded isoform of RNA helicase DDX3, rescues a hamster temperature-sensitive ET24 mutant cell line with a DDX3X mutation.
Exp Cell Res
2004
300:213-22
PubMed ID: 15383328
DOI: 10.1016/j.yexcr.2004.07.005
|
6397
Shirakawa T, Gotoh A, Zhang Z, Kao C, Chung LW, Gardner TA.
Development of human chorionic gonadotropin subunit-beta promoter-based toxic gene therapy for testicular cancer.
Urology
2004
63(3):613-8
PubMed ID: 15028478
DOI: 10.1016/j.urology.2003.09.054
|
6401
Tsuchiya Y, Nakajima M, Itoh S, Iwanari M, Yokoi T.
Expression of aryl hydrocarbon receptor repressor in normal human tissues and inducibility by polycyclic aromatic hydrocarbons in human tumor-derived cell lines.
Toxicol Sci
2003
72(2):253-9
PubMed ID: 12655030
DOI: 10.1093/toxsci/kfg022
|
6402
Nakajima M, Iwanari M, Yokoi T.
Effects of histone deacetylation and DNA methylation on the constitutive and TCDD-inducible expressions of the human CYP1 family in MCF-7 and HeLa cells.
Toxicol Lett
2003
144(2):247-56
PubMed ID: 12927368
DOI: 10.1016/s0378-4274(03)00216-9
|
2758
Harada, Hideki, Saijo, Kaoru, Watanabe, Satoru, Tsuboi, Koji, Nose, Tadao, Ishiwata, Isamu, Ohno, Tadao
Selective expansion of human natural killer cells from peripheral blood mononuclear cells by the cell line, HFWT.
Jpn J Cancer Res
2002
93:313-9
PubMed ID: 11927014
DOI: 10.1111/j.1349-7006.2002.tb02174.x
|
6399
Iwanari M, Nakajima M, Kizu R, Hayakawa K, Yokoi T.
Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differences.
Arch Toxicol
2002
76(5-6):287-98
PubMed ID: 12107646
DOI: 10.1007/s00204-002-0340-z
|
1902
Shu Qin Liu, Kaoru Saijo, Makoto Kodama, Tadao Ohno
Intelligent matrices for tumor-specific cytotoxic T lymphocytes
Materials Science and Engineering: C
1994
2:61-65
DOI: 10.1016/0928-4931(94)90030-2
|